Tiffani Taylor

436 total citations
12 papers, 268 citations indexed

About

Tiffani Taylor is a scholar working on Genetics, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tiffani Taylor has authored 12 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tiffani Taylor's work include Hemoglobinopathies and Related Disorders (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Acute Myeloid Leukemia Research (2 papers). Tiffani Taylor is often cited by papers focused on Hemoglobinopathies and Related Disorders (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Acute Myeloid Leukemia Research (2 papers). Tiffani Taylor collaborates with scholars based in United States, Croatia and India. Tiffani Taylor's co-authors include Matthew M. Hsieh, Courtney D. Fitzhugh, John F. Tisdale, Wynona Coles, Stefan Cordes, Mary Link, Jonathan D. Powell, Christopher Gamper, Elizabeth C. Wright and Neal Jeffries and has published in prestigious journals such as Blood, Journal of Dental Research and Bone Marrow Transplantation.

In The Last Decade

Tiffani Taylor

12 papers receiving 266 citations

Peers

Tiffani Taylor
Nadira Azzi Belgium
Fernando Pinto United Kingdom
Mary Link United States
Victor Aquino United States
Said Mohamed Saudi Arabia
Tiffani Taylor
Citations per year, relative to Tiffani Taylor Tiffani Taylor (= 1×) peers Franco Locatelli

Countries citing papers authored by Tiffani Taylor

Since Specialization
Citations

This map shows the geographic impact of Tiffani Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffani Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffani Taylor more than expected).

Fields of papers citing papers by Tiffani Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffani Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffani Taylor. The network helps show where Tiffani Taylor may publish in the future.

Co-authorship network of co-authors of Tiffani Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffani Taylor. A scholar is included among the top collaborators of Tiffani Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffani Taylor. Tiffani Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Leonard, Alexis, Akshay Sharma, Naoya Uchida, et al.. (2021). Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease. Blood Advances. 5(9). 2403–2411. 36 indexed citations
2.
Leonard, Alexis, Naoya Uchida, David F. Stroncek, et al.. (2019). Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor. Blood. 134(Supplement_1). 1964–1964. 2 indexed citations
3.
Uchida, Naoya, Alexis Leonard, David F. Stroncek, et al.. (2019). Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor. SSRN Electronic Journal. 2 indexed citations
4.
Steinberg, Seth M., Sandra A. Mitchell, Kristin Baird, et al.. (2017). Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients. Biology of Blood and Marrow Transplantation. 23(11). 1980–1988. 6 indexed citations
5.
Fitzhugh, Courtney D., Stefan Cordes, Tiffani Taylor, et al.. (2017). At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT. Blood. 130(17). 1946–1948. 112 indexed citations
6.
Fitzhugh, Courtney D., Matthew M. Hsieh, Tiffani Taylor, et al.. (2017). Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT. Blood Advances. 1(11). 652–661. 70 indexed citations
7.
Fitzhugh, Courtney D., Matthew M. Hsieh, Stefan Cordes, et al.. (2016). At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 128(22). 2483–2483. 3 indexed citations
8.
Fitzhugh, Courtney D., Matthew M. Hsieh, Tiffani Taylor, et al.. (2016). Post-Transplant Cyclophosphamide Improves Engraftment in Patients with Sickle Cell Disease (SCD) and Severe Organ Damage who Undergo Haploidentical Peripheral Blood Stem Cell Transplantation (PBSCT). Biology of Blood and Marrow Transplantation. 22(3). S319–S320. 1 indexed citations
9.
Steinberg, Seth M., Jennifer L. Hsu, Daniele Avila, et al.. (2015). High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis. Biology of Blood and Marrow Transplantation. 21(2). S77–S77. 1 indexed citations
10.
Williams, Kirsten M., Oleh W. Hnatiuk, Sandra A. Mitchell, et al.. (2014). NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT. Bone Marrow Transplantation. 49(4). 561–566. 8 indexed citations
12.
Bassim, Carol W., Jacqueline W. Mays, Dean Edwards, et al.. (2012). Oral Chronic Graft-vs.-Host Disease Characterization Using the NIH Scale. Journal of Dental Research. 91(7_suppl). S45–S51. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026